查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2008792

腫瘤消融市場報告：按技術、治療模式、應用方法、最終用戶和地區分類，2026-2034年

Tumor Ablation Market Report by Technology (Radiofrequency Ablation, Microwave Ablation, Cryoablation, and Others), Mode of Treatment, Mode of Application, End-User, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 149 Pages | 商品交期: 2-3個工作天內

價格

2025年，全球腫瘤消融市場規模達14億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到34億美元，2026年至2034年的複合年成長率為9.58%。推動市場成長的因素包括全球癌症患者數量的增加、醫療技術的不斷進步以及公眾對微創癌症治療日益成長的認知。

腫瘤消融術是一種無需手術切除即可去除或破壞異常組織（尤其是癌性腫瘤）的醫療程序。這種微創方法利用射頻、雷射、微波或冷凍消融等多種技術，精準標靶並清除癌細胞。此手術的關鍵優勢在於能夠最大限度地減少對周圍健康組織的損傷，從而縮短恢復時間，並提高患者的生活品質。這些治療通常在超音波、 電腦斷層掃描或MRI等影像技術的引導下進行，以提供即時數據，從而提高治療的精確度。

全球腫瘤消融市場的主要驅動力是全球癌症患者數量的不斷成長。醫療技術的持續進步進一步推動了這一成長。此外，大眾對微創癌症治療的認知度不斷提高也是重要的成長要素。同時，人口老化加劇了癌症的高發生風險，促使人們對腫瘤消融療法的投資增加。此外，醫療系統對減少手術併發症的重視也為市場創造了巨大的機會。精準醫療的興起也對市場產生了正面影響。最後，醫療保健支出的成長，尤其是在已開發國家，也推動了市場成長。其他促進因素還包括醫療旅遊的興起、先進醫療設施的普及以及廣泛的研發活動。

腫瘤消融市場的趨勢和促進因素：

以病人為中心的治療方法的興起

在當今的醫療保健領域，個人化醫療日益受到重視，它根據每位患者的獨特需求和具體情況量身定做治療方案。這種以患者為中心的轉變為腫瘤消融市場帶來了突破性的改變。透過設計治療方法時充分考慮患者的年齡、病歷和遺傳傾向等各種因素，醫療機構正在製定更有針對性、更有效的治療計劃。這種個人化方法對於癌症患者尤其重要，因為腫瘤的異質性導致治療反應因人而異。透過利用數據分析、基因組學和個人化病歷，醫療機構可以為每位患者選擇最佳的腫瘤消融療法。這種高度個人化不僅提高了治療效果，也增強了患者的滿意度和信任度，最終促使更多人選擇腫瘤消融療法。

數位科技融合的進展

將人工智慧 (AI)、機器學習和巨量資料分析等數位技術融入醫療保健系統，正在推動市場擴張。這些技術使醫療專業人員能夠基於包括患者病歷、即時監測和預測建模在內的全面數據分析，做出更明智的決策。這些數位技術的進步不僅限於患者診斷和治療計劃，它們還影響醫療保健系統的運作，從而提高管理效率、降低營運成本並提高醫療服務效率。數位技術實現了不同部門甚至不同醫療機構之間的即時資訊共用，使協調患者照護和根據需要調整治療方案變得更加容易。這種運作效率的提升不僅改善了患者的治療效果，也使腫瘤消融療法的引入對醫療保健系統更具經濟可行性。

主要企業之間的合作與收購活動增加

公共和私營部門的投資流動在市場形成中發揮著至關重要的作用。政府津貼、補貼和公共資金為醫療領域的研發提供了基礎支持。這些資金使醫學研究人員能夠在不受市場獲利能力壓力的情況下，探索腫瘤消融領域的創新技術和方法。同時，創業投資等私人投資則加速了這些新技術的商業化。公共和私人資金利益的協調一致，往往能夠將嚴謹的學術研究與市場導向結合，從而催生突破性的創新。例如，公共資金可以支持開發新型腫瘤消融技術所需的早期研究，而私人投資則可以加速臨床試驗和市場推廣，從而實現產品進入市場。這種雙管齊下的投資不僅加快了創新步伐，還創造了一個更強大、更具活力的市場環境，促進了市場競爭，並最終推動了市場成長。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 二手資訊
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球腫瘤消融市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場區隔：依技術分類
  • 市場區隔：依治療模式
  • 市場區隔：按應用模式
  • 市場區隔：依最終用戶分類
  • 市場區隔：按地區
  • 市場預測

第6章 SWOT 分析

第7章：價值鏈分析

第8章：波特五力分析

第9章 市場區隔：依技術分類

  • 射頻消融術
  • 微波消融術
  • 冷凍消融術
  • 其他

第10章 市場區隔：依治療模式分類

  • 經皮術
  • 腹腔鏡消融術
  • 外科消融術

第11章 市場區隔：依應用模式

  • 肝癌
  • 肺癌
  • 腎癌
  • 骨轉移
  • 其他

第12章 市場區隔：依最終用戶分類

  • 醫院
  • 癌症專科診所
  • 其他

第13章 市場區隔：依地區分類

  • 北美洲
  • 歐洲
  • 亞太地區
  • 中東和非洲
  • 拉丁美洲

第14章：價格分析

第15章 競爭格局

  • 市場結構
  • 主要企業
  • 主要企業簡介
    • Medtronic Public Limited Company
    • AngioDynamics Inc.
    • HealthTronics Inc.
    • NeuWave Medical, Inc.
    • INTIO Inc.
    • Galil Medical Ltd
    • Boston Scientific Corporation
    • SonaCare Medical LLC
    • EDAP TMS SA
    • Erbe Elektromedizin GmbH
    • IceCure Medical Ltd
    • MISONIX Inc.
    • Endocare Inc.
    • CooperSurgical Inc.
    • BVM Meditech Pvt
Product Code: SR112026A1629

The global tumor ablation market size reached USD 1,400 Million in 2025 . Looking forward, IMARC Group expects the market to reach USD 3,400 Million by 2034 , exhibiting a growth rate (CAGR) of 9.58 % during 2026-2034 . The increasing incidence of cancer cases across the globe, continual advancements in medical technology, and growing awareness about minimally invasive cancer treatments among the masses represent some of the factors that are propelling the market.

Tumor ablation is a medical procedure that involves the removal or destruction of abnormal tissue, particularly cancerous tumors, without the need for surgical excision. Employing various techniques such as radiofrequency, laser, microwave, or cryoablation, this minimally invasive approach targets cancerous cells and eradicates them with precision. The process is characterized by its ability to minimize damage to surrounding healthy tissues, thereby reducing recovery time and improving the patient's quality of life. These treatments are typically guided by imaging technologies such as ultrasound, CT scans, or MRI, which provide real-time data for higher accuracy.

The global market for tumor ablation is primarily driven by the increasing incidence of cancer cases across the globe. In line with this, continual advancements in medical technology are providing an impetus to the market. Moreover, the growing awareness about minimally invasive cancer treatments among the masses is acting as a significant growth-inducing factor for the market. In addition to this, the aging population, which is more susceptible to cancer, is resulting in higher investment in tumor ablation therapies. Besides this, healthcare systems' focus on reducing surgical complications is creating lucrative opportunities in the market. Also, the emergence of precision medicine is positively impacting the market. The market is further propelled by increased healthcare expenditure, particularly in developed countries. Some of the other factors contributing to the market include the rise of medical tourism, greater accessibility to advanced healthcare facilities, and extensive research and development (R&D) activities.

TUMOR ABLATION MARKET TRENDS/DRIVERS:

Rise in the patient-centric approaches

The modern healthcare landscape is increasingly focusing on personalized care, with treatments being tailored to meet the unique needs and circumstances of each patient. This shift towards patient-centricity has been a game-changer for the tumor ablation market. By designing therapies that consider various patient factors such as age, medical history, and genetic predispositions, healthcare providers are creating highly targeted and effective treatment plans. This personalized approach is particularly important for cancer patients, who often have unique therapeutic responses due to the heterogeneous nature of tumors. By leveraging data analytics, genomics, and personalized medical histories, healthcare providers are better equipped to select the most appropriate tumor ablation therapy for individual patients. This higher degree of personalization not only improves the efficacy of treatments but also increases patient satisfaction and trust, which in turn encourages more people to opt for tumor ablation therapies.

Increasing integration of digital technologies

The integration of digital technologies such as artificial intelligence (AI), machine learning, and big data analytics into healthcare systems is a driving force behind the expansion of the market. These technologies enable healthcare providers to make more informed decisions based on comprehensive data analysis, including patient histories, real-time monitoring, and predictive modeling. These digital advancements are not just limited to patient diagnosis and treatment plans. They also extend to the operational aspects of healthcare systems, streamlining the administration, reducing overhead costs, and improving the efficiency of delivering care. Digital technologies facilitate the real-time sharing of information across different departments or even different healthcare facilities, making it easier to coordinate patient care and adapt treatments as required. This enhanced operational efficiency not only improves patient outcomes but also makes the adoption of tumor ablation therapies more financially viable for healthcare systems.

Rising partnerships and acquisitions amongst key players

The influx of investment from both public and private sectors plays a critical role in shaping the market. Government grants, subsidies, and public funding serve as foundational support for research and development in the healthcare sector. These funds enable medical researchers to explore innovative techniques and technologies in tumor ablation without the immediate pressure of market viability. On the other side, private investment, often in the form of venture capital, accelerates the commercialization process of these new technologies. The alignment of public and private financial interests can often yield breakthrough innovations, as it brings together academic rigor and market-oriented approaches. For instance, public funding can support the early-stage research needed to develop a novel tumor ablation technique, while private investment can facilitate the clinical trials and marketing required to bring it to market. This dual investment stream not only accelerates the pace of innovation but also creates a more robust and dynamic market landscape, fostering competitiveness and, consequently, driving market growth.

TUMOR ABLATION INDUSTRY SEGMENTATION:

Breakup by Technology:

  • Radiofrequency (RF) Ablation
  • Microwave Ablation
  • Cryoablation
  • Others

Radiofrequency (RF) ablation represents the largest market segment

The radiofrequency (RF) ablation segment is primarily driven by its high efficacy rates, shorter procedure times, and minimally invasive nature. Technological advancements have made RF ablation more precise and safe, attracting physicians and patients alike. Moreover, the cost-effectiveness compared to traditional surgical methods has further boosted its adoption. Reimbursement policies have also been favorable, encouraging the use of RF ablation for tumor treatments. Overall, these factors contribute to its major share in the global tumor ablation market.

On the other hand, microwave, cryoablation, and other methods are becoming increasingly popular due to advancements in technology. They offer alternatives to RF ablation but tend to be more expensive and less covered by insurance. Their adoption is also limited by the need for specialized training for healthcare providers. Despite these challenges, they hold a minor but growing segment in the market.

Breakup by Mode of Treatment:

  • Percutaneous Ablation
  • Laparoscopic Ablation
  • Surgical Ablation

Surgical ablation accounts for the majority of the market share

Surgical ablation remains a conventional and highly effective approach for treating various types of tumors. It is often recommended for cases where the tumor is large or not amenable to minimally invasive techniques. Given the invasive nature, surgical ablation usually necessitates longer hospital stays and recovery periods, which can be a downside. However, its proven efficacy and completeness in tumor removal secure its significant role in the global market.

On the other hand, percutaneous and laparoscopic methods are minimally invasive and preferred for small to medium-sized tumors. These techniques are cost-effective but require specialized equipment and training. Their minor market share is partly due to limitations in treating complex or larger tumors. Nonetheless, they remain valuable options in the broader scope of ablation methods.

Breakup by Mode of Application:

  • Liver Cancer
  • Lung Cancer
  • Kidney Cancer
  • Bone Metastasis
  • Others

Liver cancer represents the largest market segment

Liver cancer dominates the global tumor ablation market, largely due to the high incidence and mortality rates associated with this disease. The ablation techniques offer a viable treatment option for early-stage liver cancer, where surgical removal may not be feasible. As liver cancer is often diagnosed at an advanced stage, ablation techniques are viewed as essential palliative treatments. High adoption rates and the emphasis on research for liver cancer ablation contribute to its significant market share.

On the other hand, the other segments including lung, kidney, and bone metastasis are gradually gaining traction due to technological improvements. These cancers are typically treated with other therapies, but ablation is becoming a more common secondary or complementary option. Limitations in insurance coverage and less substantial clinical evidence compared to major segments hold back their market share.

Breakup by End-User:

  • Hospitals
  • Cancer Specialty Clinics
  • Others

Hospitals accounts for the majority of the market share

Hospitals constitute a significant share of the market due to their comprehensive healthcare services and accessibility to a wide patient demographic. They have the financial capability to invest in advanced ablation technologies, and their multidisciplinary teams can offer a variety of treatment options. With the increasing incidence of cancer, hospitals continue to adopt tumor ablation techniques, solidifying their role in the global market.

On the other hand, specialized cancer clinics focus exclusively on cancer treatment, making them ideal centers for advanced ablation therapies. These clinics often have cutting-edge technologies and highly skilled specialists, which makes them attractive for patients seeking specialized care. However, these centers may not be as widespread as hospitals, limiting their accessibility. Their specific focus and expertise, though, contribute to an increasing share in the global market.

Breakup by Region:

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

North America exhibits a clear dominance, accounting for the largest tumor ablation market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America; Europe; Asia Pacific; the Middle East and Africa; and Latin America. According to the report, North America accounted for the largest market share.

North America holds a dominant position in the global market, driven by a number of factors including high healthcare expenditure, advanced medical technologies, and a robust healthcare infrastructure. The region also benefits from favorable reimbursement policies, which make various ablation treatments more accessible to patients. Furthermore, the prevalence of cancer is relatively high in North America, leading to greater demand for effective treatment methods such as tumor ablation.

Research and development (R&D) activities in the region are vigorous, further propelling the adoption of new and improved ablation techniques. Pharmaceutical and medical device companies in North America also contribute to market growth by investing in research, thereby enhancing the technology and its applications. The presence of key market players headquartered in the region adds to the competitive advantage. Educational campaigns and patient awareness programs are also more prevalent here, aiding in early diagnosis and treatment.

COMPETITIVE LANDSCAPE:

Leaders in the global tumor ablation market are dedicating resources to clinical trials and research to improve the efficacy and safety of their solutions. They are also focusing on developing minimally invasive techniques to cater to patient comfort and faster recovery. Telehealth integrations are in progress to facilitate remote consultations, thereby increasing the adoption rate of their products. Regulatory approvals are a key focus, and as such, these entities are navigating complex compliance landscapes both domestically and internationally. To maintain a competitive edge, alliances with healthcare providers and medical institutions, and implementation of robust after-sales support and training programs are being formed. Furthermore, educational programs for healthcare professionals are being launched to foster proper utilization of the technology.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Medtronic Public Limited Company
  • AngioDynamics Inc.
  • HealthTronics Inc.
  • NeuWave Medical, Inc.
  • INTIO Inc.
  • Galil Medical Ltd
  • Boston Scientific Corporation
  • SonaCare Medical LLC
  • EDAP TMS S.A.
  • Erbe Elektromedizin GmbH
  • IceCure Medical Ltd
  • MISONIX Inc.
  • Endocare Inc.
  • CooperSurgical Inc.
  • B V M Meditech Pvt

KEY QUESTIONS ANSWERED IN THIS REPORT

1. What was the size of the global tumor ablation market in 2025?

2. What is the expected growth rate of the global tumor ablation market during 2026-2034?

3. What has been the impact of COVID-19 on the global tumor ablation market?

4. What are the key factors driving the global tumor ablation market?

5. What is the breakup of the global tumor ablation market based on the technology?

6. What is the breakup of the global tumor ablation market based on the mode of treatment?

7. What is the breakup of the global tumor ablation market based on mode of application?

8. What is the breakup of the global tumor ablation market based on the end-user?

9. What are the key regions in the global tumor ablation market?

10. Who are the key players/companies in the global tumor ablation market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Tumor Ablation Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Technology
  • 5.5 Market Breakup by Mode of Treatment
  • 5.6 Market Breakup by Mode of Application
  • 5.7 Market Breakup by End-User
  • 5.8 Market Breakup by Region
  • 5.9 Market Forecast

6 SWOT Analysis

  • 6.1 Overview
  • 6.2 Strengths
  • 6.3 Weaknesses
  • 6.4 Opportunities
  • 6.5 Threats

7 Value Chain Analysis

8 Porter's Five Forces Analysis

  • 8.1 Overview
  • 8.2 Bargaining Power of Buyers
  • 8.3 Bargaining Power of Suppliers
  • 8.4 Degree of Competition
  • 8.5 Threat of New Entrants
  • 8.6 Threat of Substitutes

9 Market Breakup by Technology

  • 9.1 Radiofrequency (RF) Ablation
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Microwave Ablation
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Cryoablation
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Mode of Treatment

  • 10.1 Percutaneous Ablation
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Laparoscopic Ablation
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Surgical Ablation
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Mode of Application

  • 11.1 Liver Cancer
    • 11.1.1 Market Trends
    • 11.1.2 Market Forecast
  • 11.2 Lung Cancer
    • 11.2.1 Market Trends
    • 11.2.2 Market Forecast
  • 11.3 Kidney Cancer
    • 11.3.1 Market Trends
    • 11.3.2 Market Forecast
  • 11.4 Bone Metastasis
    • 11.4.1 Market Trends
    • 11.4.2 Market Forecast
  • 11.5 Others
    • 11.5.1 Market Trends
    • 11.5.2 Market Forecast

12 Market Breakup by End-User

  • 12.1 Hospitals
    • 12.1.1 Market Trends
    • 12.1.2 Market Forecast
  • 12.2 Cancer Specialty Clinics
    • 12.2.1 Market Trends
    • 12.2.2 Market Forecast
  • 12.3 Others
    • 12.3.1 Market Trends
    • 12.3.2 Market Forecast

13 Market Breakup by Region

  • 13.1 North America
    • 13.1.1 Market Trends
    • 13.1.2 Market Forecast
  • 13.2 Europe
    • 13.2.1 Market Trends
    • 13.2.2 Market Forecast
  • 13.3 Asia Pacific
    • 13.3.1 Market Trends
    • 13.3.2 Market Forecast
  • 13.4 Middle East and Africa
    • 13.4.1 Market Trends
    • 13.4.2 Market Forecast
  • 13.5 Latin America
    • 13.5.1 Market Trends
    • 13.5.2 Market Forecast

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Medtronic Public Limited Company
    • 15.3.2 AngioDynamics Inc.
    • 15.3.3 HealthTronics Inc.
    • 15.3.4 NeuWave Medical, Inc.
    • 15.3.5 INTIO Inc.
    • 15.3.6 Galil Medical Ltd
    • 15.3.7 Boston Scientific Corporation
    • 15.3.8 SonaCare Medical LLC
    • 15.3.9 EDAP TMS S.A.
    • 15.3.10 Erbe Elektromedizin GmbH
    • 15.3.11 IceCure Medical Ltd
    • 15.3.12 MISONIX Inc.
    • 15.3.13 Endocare Inc.
    • 15.3.14 CooperSurgical Inc.
    • 15.3.15 B V M Meditech Pvt

List of Figures

  • Figure 1: Global: Tumor Ablation Market: Major Drivers and Challenges
  • Figure 2: Global: Tumor Ablation Market: Sales Value (in Million USD), 2020-2025
  • Figure 3: Global: Tumor Ablation Market: Breakup by Technology (in %), 2025
  • Figure 4: Global: Tumor Ablation Market: Breakup by Mode of Treatment (in %), 2025
  • Figure 5: Global: Tumor Ablation Market: Breakup by Mode of Application (in %), 2025
  • Figure 6: Global: Tumor Ablation Market: Breakup by End-User (in %), 2025
  • Figure 7: Global: Tumor Ablation Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Tumor Ablation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 9: Global: Tumor Ablation Industry: SWOT Analysis
  • Figure 10: Global: Tumor Ablation Industry: Value Chain Analysis
  • Figure 11: Global: Tumor Ablation Industry: Porter's Five Forces Analysis
  • Figure 12: Global: Tumor Ablation (Radiofrequency Ablation) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Tumor Ablation (Radiofrequency Ablation) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Tumor Ablation (Microwave Ablation) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Tumor Ablation (Microwave Ablation) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Tumor Ablation (Cryoablation) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Tumor Ablation (Cryoablation) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Tumor Ablation (Other Technologies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Tumor Ablation (Other Technologies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Tumor Ablation (Percutaneous Ablation) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Tumor Ablation (Percutaneous Ablation) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Tumor Ablation (Laparoscopic Ablation) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Tumor Ablation (Laparoscopic Ablation) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Tumor Ablation (Surgical Ablation) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Tumor Ablation (Surgical Ablation) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Tumor Ablation (Liver Cancer) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Tumor Ablation (Liver Cancer) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Global: Tumor Ablation (Lung Cancer) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Global: Tumor Ablation (Lung Cancer) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Global: Tumor Ablation (Kidney Cancer) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Global: Tumor Ablation (Kidney Cancer) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: Global: Tumor Ablation (Bone Metastasis) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: Global: Tumor Ablation (Bone Metastasis) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Global: Tumor Ablation (Other Mode of Applications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Global: Tumor Ablation (Other Mode of Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: Global: Tumor Ablation (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: Global: Tumor Ablation (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: Global: Tumor Ablation (Cancer Specialty Clinics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: Global: Tumor Ablation (Cancer Specialty Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: Global: Tumor Ablation (Other End-Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: Global: Tumor Ablation (Other End-Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: North America: Tumor Ablation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: North America: Tumor Ablation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: Europe: Tumor Ablation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: Europe: Tumor Ablation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Asia Pacific: Tumor Ablation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Asia Pacific: Tumor Ablation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Middle East and Africa: Tumor Ablation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Middle East and Africa: Tumor Ablation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: Latin America: Tumor Ablation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: Latin America: Tumor Ablation Market Forecast: Sales Value (in Million USD), 2026-2034

List of Tables

  • Table 1: Global: Tumor Ablation Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Tumor Ablation Market Forecast: Breakup by Technology (in Million USD), 2026-2034
  • Table 3: Global: Tumor Ablation Market Forecast: Breakup by Mode of Treatment (in Million USD), 2026-2034
  • Table 4: Global: Tumor Ablation Market Forecast: Breakup by Mode of Application (in Million USD), 2026-2034
  • Table 5: Global: Tumor Ablation Market Forecast: Breakup by End-User (in Million USD), 2026-2034
  • Table 6: Global: Tumor Ablation Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 7: Global: Tumor Ablation Market Structure
  • Table 8: Global: Tumor Ablation Market: Key Players